Pyxis Oncology, Inc. (PYXS)
3.49
-0.40
(-10.28%)
USD |
NASDAQ |
Sep 09, 14:40
Pyxis Oncology Price to Book Value : 19.35 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 21.57 |
| September 04, 2026 | 21.57 |
| September 03, 2026 | 19.77 |
| September 02, 2026 | 20.79 |
| September 01, 2026 | 19.08 |
| August 31, 2026 | 17.97 |
| August 28, 2026 | 17.91 |
| August 27, 2026 | 18.41 |
| August 26, 2026 | 18.52 |
| August 25, 2026 | 16.97 |
| August 24, 2026 | 16.41 |
| August 21, 2026 | 17.08 |
| August 20, 2026 | 17.30 |
| August 19, 2026 | 18.69 |
| August 18, 2026 | 16.58 |
| August 17, 2026 | 16.75 |
| August 14, 2026 | 16.69 |
| August 13, 2026 | 16.69 |
| August 12, 2026 | 17.63 |
| August 11, 2026 | 15.69 |
| August 10, 2026 | 21.24 |
| August 07, 2026 | 20.68 |
| August 06, 2026 | 20.79 |
| August 05, 2026 | 17.36 |
| August 04, 2026 | 17.52 |
| Date | Value |
|---|---|
| August 03, 2026 | 16.86 |
| July 31, 2026 | 14.69 |
| July 30, 2026 | 15.91 |
| July 29, 2026 | 16.19 |
| July 28, 2026 | 16.14 |
| July 27, 2026 | 16.14 |
| July 24, 2026 | 14.47 |
| July 23, 2026 | 14.86 |
| July 22, 2026 | 14.03 |
| July 21, 2026 | 12.37 |
| July 20, 2026 | 12.48 |
| July 17, 2026 | 13.09 |
| July 16, 2026 | 12.37 |
| July 15, 2026 | 13.47 |
| July 14, 2026 | 12.70 |
| July 13, 2026 | 13.53 |
| July 10, 2026 | 14.81 |
| July 09, 2026 | 14.64 |
| July 08, 2026 | 14.92 |
| July 07, 2026 | 17.02 |
| July 06, 2026 | 13.64 |
| July 02, 2026 | 14.58 |
| July 01, 2026 | 15.80 |
| June 30, 2026 | 16.69 |
| June 29, 2026 | 5.747 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.672 |
| Alnylam Pharmaceuticals, Inc. | 25.11 |
| Anika Therapeutics, Inc. | 2.050 |
| Savara, Inc. | 7.728 |
| Vericel Corp. | 5.403 |
Price to Book Value Related Metrics
| PS Ratio | 19.98 |
| Price | 3.49 |
| Earnings Yield | -40.21% |
| Market Cap | 221.39M |